Family physicians' knowledge of risk factors for cervical cancer

Journal of Women's Health

Volumn 12, Issue 6, 2003, Pages 561-567

  Ruffin IV, Mack T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER RISK; CANCER SCREENING; COMPREHENSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; GENDER; GENERAL PRACTICE; GENERAL PRACTITIONER; GEOGRAPHY; HUMAN; LEARNING; MALE; MEDICAL EDUCATION; MEDICAL SOCIETY; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RACE; UTERINE CERVIX CANCER;

EID: 0041377975     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099903768248267     Document Type: Article

References (52)

1. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193.
2. Ayre JE. Selective cytology smear for diagnosis of cancer. Am J Obstet Gynecol 1947;53:609.
3. Nieburgs HE. A comparative study of different techniques for the diagnosis of cervical carcinoma. Am J Obstet Gynecol 1956;72:511.
4. Nieburgs HE. Review of techniques of cervical smears. Acta Cytol 1960;4:226.
5. Ho Yuen B, Fidler HK, Boyes DA. In situ carcinoma of the uterine cervix. CMAJ Canadian Medical Journal 1968;99:719.
6. Ruch RM, Blake C, Abou A, Lado M, Ruch WAJ. The changing incidence of cervical carcinoma. Am J Obstet Gynecol 1964;89:727.
7. Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia. J Obstet Gynaecol Br Commonw 1968;75:392.
8. Cervical cancer screening programs. IV. Relations between screening programs for carcinoma of the cervix and other screening and preventive programs in Canada. Can Med Assoc J 1976;114:1031.
9. Cervical cancer screening programs. III. Components of a practical screening program for carcinoma of the cervix. Can Med Assoc J 1976;114:1027.
10. Cervical cancer screening programs. II. Screening for carcinoma of the cervix. Can Med Assoc J 1976;114: 1013.
11. Cervical cancer screening programs. V. Conclusions and recommendations of the task force. Can Med Assoc J 1976;114:1033.
12. Dawang Y, Jufang Y, Shoufu X, Yixian L. Mass cytologic screening for cervical carcinoma in China. A review of 7,735,057 reported cases. Acta Cytol 1985;29:341.
13. Smith R, Mettlin C, Davis K, Eyre H. American Cancer Society guidelines for early detection of cancer. CA Cancer J Clin 2000;50:34.
14. Janicek M, Averette H. Cervical cancer: Prevention, diagnosis and therapeutics. CA Cancer J Clin 2001; 51:92.
15. Screening for cervical cancer. In: DiGuiseppi C, Atkins D, Woolf S, eds. Guide to clinical preventive services: Report of the U.S. Preventive Services Task Force. Baltimore: Williams & Wilkins, 1996:105.
16. Smith R, Cokkinides V, Eyre H. Amercian Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003;53:27.
17. Dillman D. Mail and telephone surveys: The total design method. New York: John Wiley & Sons, 1978.
18. Fink DJ. Change in American Cancer Society checkup guidelines for detection of cervical cancer. CA Cancer J Clin 1988;38:127.
19. Frame PS, Frame SJ. Determinants of cancer screening frequency: The example of screening for cervical cancer. J Am Board Fam Pract 1998;11:87.
20. Hulka BS. Risk factors for cervical cancer. J Chronic Dis 1982;35:3.
21. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973; 33:1353.
22. Boyd JT, Doll R. A study of the aetiology of carcinoma of the cervix uteri. Br J Cancer 1964;18:419.
23. Rotkin ID. Sexual characteristics of a cervical cancer population. Am J Public Health 1967;57:815.
24. de Vet HCW, Sturmans F. Risk factors for cervical dysplasia: Implications for prevention. Public Health 1994;108:241.
25. Thomas DB, Ray RM, Pardthaisong T, et al. Prostitution, condom use, and invasive squamous cell cervical cancer in Thailand. Am J Epidemiol 1996;143:779.
26. Terris M, Wilson F, Smith H, Sprung E, Nelson JH. The relationship of coitus to carcinoma of the cervix. Am J Public Health 1967;57:840.
27. Harris RWC, Brinton LA, Cowdell RH, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer 1980;42:359.
28. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst 1986;77:1063.
29. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958.
30. Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1995;87:1345.
31. Winkelstein WJ, Shillitoe EJ, Brand R, Johnson KK. Further comments on cancer of the uterine cervix, smoking, and herpesvirus infection. Am J Epidemiol 1984;119:1.
32. Koss LG, Stewart FW, Foote FW, Jordan MJ, Bader GM, Day E. Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix. Cancer 1963;16:1160.
33. Christopherson WM, Gray LAS. Dysplasia and preclinical carcinoma of the uterine cervix: Diagnosis and management. Semin Oncol 1982;9:265.
34. de Vet HC, Sturmans F, Knipschild PG. The role of cigarette smoking in the etiology of cervical dysplasia. Epidemiology 1994;5:631.
35. Clarke EA, Morgan RW, Newman AM. Smoking as a risk factor in cancer of the cervix: Additional evidence from a case-control study. Am J Epidemiol 1982;115: 59.
36. Hellberg D, Valentin J, Nilsson S. Smoking and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1986;65:625.
37. La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 1986;123:22.
38. Lyon JL, Gardner JW, West DW, Stanish WM, Hebertson RM. Smoking and carcinoma in situ of the uterine cervix. Am J Public Health 1983;73:558.
39. Sasson IM, Haley NJ, Hoffmann D, Wynder EL, Hellberg D, Nilsson S. Cigarette smoking and neoplasia of the uterine cervix: Smoke constituents in cervical mucus. N Engl J Med 1985;312:315.
40. Stellman SD, Austin H, Wynder EL. Cervix cancer and cigarette smoking: A case-control study. Am J Epidemiol 1980;111:383.
41. Trevathan E, Layde P, Webster LA, Adams JB, Benigno BB, Ory H. Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. JAMA 1983;250:499.
42. Morell ND, Taylor JR, Snyder RN, Ziel HK, Saltz A, Willie S. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed. Obstet Gynecol 1982;60:41.
43. Martin PL. How preventable is invasive cervical cancer? A community study of preventable factors. Am J Obstet Gynecol 1972;113:541.
44. Carmichael JA, Jeffrey JF, Steele HD, Ohlke ID. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 1984;148:685.
45. Anderson B, Watring WG, Edinger DDJ, Small EC, Netland AT, Safaii H. Development of DES-associated clear-cell carcinoma: The importance of regular screening. Obstet Gynecol 1979;53:293.
46. Piver MS, Lele SB, Baker TR, Sandecki A. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic. Cancer Detect Prev 1988; 11:197.
47. Group IW. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes. Br Med J Clin Res Ed 1986;293:659.
48. Boon ME, de Graaff Guilloud JC, Rietveld WJ, Wijsman-Grootendorst A. Effect of regular 3-yearly screening on the incidence of cervical smears: The Leiden experience. Cytopathology 1990;1:201.
49. Weisman CS, Celentano DD, Hill MN, Teitelbaum MA. Pap testing: Opinion and practice among young obstetrician-gynecologists. Prev Med 1986;15:342.
50. Bowman JA, Redman S, Reid ALA, Sanson-Fisher RW. General practitioners and the provision of Papanicolaou smear-tests: Current practice, knowledge and attitudes. Med J Aust 1990;152:178.
51. Blackman D, Bennett E, Miller D. Trends in self-reported use of mammograms (1989-1997) and Papanicolaou test (1991-1997)-Behavioral risk factor surveillance system. MMWR 1999;48:1.
52. Healthy People 2000 Final Report. Hyattesville, MD: National Center for Health Statistics, 2001.